Biofilms are a worldwide problem. A problem that needs a solution. Quiescence Technologies has that solution - smart microbial control.
The global human and economic costs caused by bacterial biofilms are enormous, from healthcare through to the agrochemical and petroleum industries. When bacteria settle and begin to colonise surfaces they communicate with each other. By releasing signaling molecules in a process called quorum sensing, they can coordinate the generation of toxins and the creation of biofilms, in order to defend themselves.
Quiescence Technologies is commercializing novel quorum sensing blocker (QSB) technology which affects this signaling and has led to the identification of substances which inhibit bacterial colonization and biofilm development. This breakthrough technology offers means of preventing the consequences of bacterial infection whilst avoiding the development of resistance and toxicity, and, in addition, opening completely new application opportunities.
The breadth of the technology puts Quiescence Technologies in a leading position to address the ever increasing need, and the multi-billion dollar markets, for safer, more effective agents in the worldwide fight against infection and the damage caused by bacterial biofilms.
Quiescence Technologies™ LLC was established in December 2006 by XL TechGroup, Inc.